-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
For patients with acute coronary syndrome who require coronary artery bridge surgery, the best antiplate plate plate strategy is not yet clear.
but more effective antiplatelete therapy can easily lead to peri-surgical bleeding.
The concept of plate platetation is a long-standing concept, recently published in JAHA, an authoritative journal in the field of cardiovascular disease, a research article, the study assumes that the residual plate plateast inhibition obtained through the treatment of "plate platetation" can delay the time of coronary bridge, and has ischemia protection.
meta-analysis, the researchers compared patients with coronary arterial bridge surgery who had received more effective antiplate plateplate suppression strategies and less effective plateplate suppression strategies, respectively.
main outcome of the study was the total cause of death in patients after bypass surgery.
meta-analysis identified four randomized studies and six non-randomized studies of antiplate plate plate therapy.
In all studies, the overall mortality rate of coronary arterial bridge surgery patients who received less effective plateplate suppression strategies was higher than that of coronary artery bridge surgery patients who received more effective antiplate plate plate suppression strategies (ratio ratio was 1.38; 95% confidence interval was 1.03-1.85; P=0.03).
results support the role of plate plate rest in reducing mortality in patients with acute coronary artery syndrome who require coronary artery bridge surgery.
suggests that in patients with acute coronary artery syndrome, more effective antiplate platea therapy strategies should be routinely used in advance, regardless of whether coronary artery bridge is accepted or not.